Riskpilot← Back to searchSign inGet full accessALMEDOC AS
ASActiveOrg 979659938Grimelundsveien 4B, 0775 OsloOther human health activities n.e.c. · NACE 8699Est. 19981 employees
Revenue 2024
NOK 0
EBITDA margin
—
-61% vs 2023
Equity ratio
26.3%
Financial strength
Net profit 2024
NOK -329K
-14736% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -351K | -61% |
| Net profit | NOK -329K | -14736% |
| Total assets | NOK 3,7M | -2% |
| Equity | NOK 983K | -25% |
| Employees | 1 | — |
Legal name
ALMEDOC AS
Org number
979659938
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
24. februar 1998
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Grimelundsveien 4B, 0775 Oslo
Phone
+4723201180
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 326 | 7 139 | 3 631 | 171 | 0 |
| Staff expenses | −276 | −271 | −262 | −45 | −0 |
| EBITDA | 4 140 | 4 647 | 1 661 | −218 | −351 |
| Depreciation & amort. | −208 | −201 | −6 | −0 | −0 |
| EBIT | 3 932 | 4 446 | 1 655 | −218 | −351 |
| Net financials | 820 | 481 | 1 331 | 188 | −48 |
| Profit before tax | 4 753 | 4 927 | 2 986 | −30 | −399 |
| Tax | 884 | 978 | 438 | −28 | −70 |
| Net profit | 3 868 | 3 949 | 2 548 | −2 | −329 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 063 | 7 348 | 4 918 | 3 824 | 3 732 |
| Equity | 2 213 | −1 234 | 1 314 | 1 312 | 983 |
| Long-term debt | 83 | 29 | 183 | 102 | 32 |
| Short-term debt | 6 767 | 8 552 | 3 420 | 2 410 | 2 718 |
| Total debt | 6 850 | 8 581 | 3 603 | 2 511 | 2 749 |
EBITDA margin
-35078500.0%
This company
15.8%
Market median
-222015923% vs market
20202024
Equity ratio
26.3%
This company
38.2%
Market median
-31% vs market
20202024
Return on equity
-33.4%
This company
18.4%
Market median
-282% vs market
20202024
Net profit margin
-32891100.0%
This company
8.1%
Market median
-406063063% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.80×
This company
0.62×
Market median
-352% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 1998 | |
| Board of Directors | 1998 | |
| Chairman | 1998 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ALMEDOC AS 
OSLO KOSMETISKE LASERSENTER ASBoard members of ALMEDOC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sidsel Gedde-Dahl Alme | Board of Directors | 0 companies |
| Charlotte Alme | Board of Directors | 0 companies |
| Gunnar Alme | Chairman | 0 companies |